Insider Trims Stake in Mirion Technologies by $165K: What Investors Should Know
The Motley Fool
·
52d ago
MIR
Mirion Technologies, Inc. NYQ · MIR
$15.97
-0.19
(-1.18%)
Pullback · -1.16σ
Price alert —
Loading…
Sign in to get a one-time email the moment MIR crosses your price. Free accounts included.
Sign in / create a free account
This Nuclear Tech Stock Grew Revenue 27%, But a Fund Still Slashed Its Stake
The Motley Fool
·
64d ago
Global Medical Radiation Detection Devices Market to Increase at a Steady Growth Rate of ~7% by 2032 | DelveInsight
GlobeNewswire Inc.
·
170d ago
Why Mirion Technologies Rallied Double Digits Today
The Motley Fool
·
262d ago
Mirion (MIR) Q2 Revenue Up 8%
The Motley Fool
·
350d ago
CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring
GlobeNewswire Inc.
·
522d ago
Top 5 Tech Stocks That May Crash In February
Benzinga
·
1249d ago
MedMira Strengthens and Expands Board
GlobeNewswire Inc.
·
1465d ago
MedMira Reports Third Quarter Results FY2022
GlobeNewswire Inc.
·
1480d ago
MedMira Receives Patent for its Unique Quantitative Diagnostic System
GlobeNewswire Inc.
·
1503d ago
MedMira provides an update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market
GlobeNewswire Inc.
·
1513d ago
VYRA™ Product Line Update
GlobeNewswire Inc.
·
1520d ago
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test
GlobeNewswire Inc.
·
1528d ago
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022
Benzinga
·
1577d ago
MedMira receives the CE mark for its Reveal® TP (Syphilis) and starts clinical trials in Canada
GlobeNewswire Inc.
·
1592d ago
MedMira Receives CE Marking for its REVEALCOVID-19® PLUS Total Antibody Test
GlobeNewswire Inc.
·
1621d ago
MedMira Provides a Pre-Annual General Meeting Update
GlobeNewswire Inc.
·
1625d ago
MedMira Announces VYRA™ CoV2Flu and Additional Regulatory Opportunities
GlobeNewswire Inc.
·
1670d ago
MedMira strengthen its Board with New Appointment
GlobeNewswire Inc.
·
1674d ago
MedMira announces significant debt reduction and additional growth capital
GlobeNewswire Inc.
·
1677d ago
MedMira Reports FY2021 Fourth Quarter and Year End Financial Results
GlobeNewswire Inc.
·
1691d ago